Sivahari Gorantla | Health Sciences | Best Researcher Award

Posted on by Forensic Scientist

Dr. Sivahari Gorantla | Health Sciences | Best Researcher Award

Dept Of Hematology And Oncology | Germany

Dr. Sivahari Prasad Gorantla, born on July 25, 1980, in India, is a Junior Group Leader at the Signal Transduction Lab at the University Medical Center, Universitätsklinikum Schleswig-Holstein, Campus Lübeck. His research focuses on molecular therapeutics, targeted therapy, and drug resistance mechanisms. He is recognized for his groundbreaking work in the development of therapies targeting JAK2 and other kinases in myeloproliferative neoplasms.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Research Experience: Dr. Gorantla’s research spans a wide range of significant areas, including molecular therapeutics, cancer research, and drug resistance mechanisms, making him a key contributor to advancements in these fields.

  • Outstanding Publication Record: His research publications in high-impact journals such as Nature Communications, Leukemia, and Molecular Oncology highlight his ability to generate novel and impactful insights in his field.

  • International Recognition and Honors: Dr. Gorantla has received multiple awards, including the “Young Investigator Prize” from DGHO and the “Abstract Achievement Award” from the American Association of Hematology. His recognition by prestigious organizations indicates his high standing in the scientific community.

  • Successful Grant Acquisition: His ability to secure substantial research grants from prestigious sources (e.g., DAAD, DFG, Wegener Foundation) is a testament to his research credibility and the relevance of his work.

  • Teaching and Mentoring: His involvement in teaching medical students and master’s students, particularly in the areas of molecular life sciences and genomics, showcases his dedication to education and mentoring the next generation of researchers.

Education 🎓

Dr. Gorantla completed his Ph.D. in Hematology and Oncology from Klinikum rechts der Isar, TUM in 2010. He then pursued multiple postdoctoral fellowships, including at the University Clinic Freiburg and the prestigious Hematology and Oncology department at TUM. His academic journey also includes a Master’s in Biotechnology from the University of Calicut.

Experience 💼

Dr. Gorantla’s career spans several key positions, including Assistant Professor at the University of Hyderabad, India, and Independent Postdoctoral Fellow at University Clinic Freiburg. His work involves leading research in molecular mechanisms behind cancer resistance to therapy and the development of novel therapeutic strategies. He currently holds his position as Junior Group Leader at the University Medical Center Lübeck.

Research Interests On Health Sciences 🔬

Dr. Gorantla’s research revolves around molecular therapeutics, targeted therapy, and mechanisms of drug resistance, particularly in blood cancers like leukemia and myeloproliferative neoplasms. He has contributed to understanding the role of JAK2 and other kinases in resistance to treatment, paving the way for novel treatment strategies.

Awards 🏆

Throughout his career, Dr. Gorantla has earned several prestigious accolades. Notable among them are the Young Investigator Prize by DGHO (German Hematology Association) in 2010 and the Abstract Achievement Award from the American Association of Hematology in 2013. He has also been a finalist for the AACR Scholar-in-Training Award and won multiple travel awards at major hematology conferences.

Publications 📚

Dr. Gorantla has authored numerous impactful publications in the field of oncology. Some of his significant works include:

  • Gorantla SP, Rassner M, et al. Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is mediated mainly by targeting pro-inflammatory cytokine signaling not oncogenic signaling (Accepted in Nature Communications, 2024). Nature Communications

  • Gorantla SP, Oelschlager L, et al. Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation (Accepted in Leukemia, 2024). Leukemia Journal

  • Gorantla SP, Mueller TA, et al. A newly identified 45-kDa JAK2 variant (Mol Oncol, 2024). Mol Oncol
    His work is widely cited in the field, with articles being referenced by researchers and clinicians worldwide.

Conclusion 🌍

Dr. Sivahari Prasad Gorantla has emerged as a leader in the field of molecular oncology, particularly in the development of targeted therapies for blood cancers. His dedication to research, extensive experience, and numerous accolades make him a valuable contributor to scientific advancements in cancer treatment. With ongoing research grants and fellowships, Dr. Gorantla continues to push the boundaries of medical science, offering new hope for cancer patients worldwide.

Marta Wojcik | Medicine | Best Researcher Award

Posted on by Forensic Scientist

Assoc. Prof. Dr. Marta Wojcik | Medicine | Best Researcher Award

Head of Veterinary Oncology lab | University of Live Sciences in Lublin | Poland

Dr. Marta Wójcik is the Head of the Veterinary Oncology Laboratory at the Department of Epizootiology and Clinic of Infectious Diseases, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Poland. With a distinguished career in veterinary pathology, her research primarily focuses on liver diseases, especially the mechanisms leading to primary malignant tumors such as hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCA). Her work encompasses both experimental models and in vitro analyses, contributing significantly to the understanding of hepatocarcinogenesis.

Profile

Orcid

Scopus

Strengths for the Awards

  • Extensive Research Contributions:
    • Dr. Wójcik has a well-established research background, primarily focusing on veterinary oncology and liver diseases.
    • Her work in hepatocarcinogenesis, fibrosis, and liver disease mechanisms has both veterinary and human medicine implications.
    • Multiple research projects, including leading and participating in grants funded by the National Science Centre in Poland and the Polish Ministry of Science and Higher Education.
  • International Scientific Collaborations:
    • Ongoing collaboration with the National Research Council in Pisa, Italy on liver cancer and hepatocytes research.
    • Erasmus-funded research and teaching exchanges in Germany, Italy, and Hungary, demonstrating strong international networking.
  • Publication Record & Reviewer Role:
    • Publications in high-impact factor journals, indicating significant contributions to veterinary and medical research.
    • Peer reviewer for reputed journals, including Molecules, The American Journal of the Medicine Sciences, and Oncology Letters.
  • Academic Leadership & Teaching:
    • Head of the Veterinary Oncology Lab, indicating leadership in her field.
    • Supervisor of PhD students and mentor for undergraduate students in veterinary medicine.
    • Teaches advanced courses in Pathophysiology, Oncology, and Laboratory Animal Diseases, which strengthens her role in academia.

Education 🎓

Dr. Wójcik earned her Doctor of Veterinary Medicine (DVM) degree in 1996 from the Agricultural Academy in Lublin. She pursued her Ph.D. at the University of Life Sciences in Lublin, completing it in 2005 with a dissertation titled “Changes in the secretion of Ubiquinone Q10 and secretory parameters of bile in the course of experimental hepatic oxidative stress in sheep.” In 2019, she achieved habilitation with a thesis on the activity of oval stem cells and macrophages in primary hepatic cancer in humans and rats.

Experience 🏢

Beginning her career as a research fellow at the Department of Pathophysiology, University of Life Sciences in Lublin, from 1996 to 2005, Dr. Wójcik then served as an Assistant Professor at the Faculty of Veterinary Medicine until 2019. Since 2020, she has been an Associate Professor, leading the Veterinary Oncology Laboratory. Her international experience includes scholarships and teaching engagements in Germany, Italy, and Hungary, enhancing her global perspective in veterinary medicine.

Research Interests On Medicine 🔬

Dr. Wójcik’s research delves into the pathomechanisms of liver diseases, with a particular emphasis on cancer processes leading to primary malignant tumors. She utilizes experimental rat models and in vitro analyses to study hepatocarcinogenesis. Her recent work focuses on the influence of “trained” M1 macrophages on isolated neoplastic cells and the impact of nutraceuticals on HCC development.

Awards and Recognitions 🏆

Throughout her career, Dr. Wójcik has been recognized for her contributions to veterinary pathology and hepatology. She has secured funding from prestigious institutions, including the National Science Centre in Poland and the Polish Ministry of Science and Higher Education, to support her groundbreaking research projects.

Publications 📚

  1. A Moderate Intake of Beer Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a High-Fat Diet (HFD)-Induced Mouse Model
    • Authors: Vornoli, A., Souid, A., Lazzari, B., Capra, E., Pozzo, L.
    • Publication Year: 2024
    • Citations: 0
  2. Liver Antioxidant Capacity and Steatosis in Laying Hens Exposed to Various Quantities of Lupin (Lupinus angustifolius) Seeds in the Diet
    • Authors: Wójcik, M., Grabowski, S., Jarosz, Ł.S., Gruszczyński, K., Marek, A.
    • Publication Year: 2024
    • Citations: 1
  3. Growth Rate and Bone Hydroxyproline Concentration in Turkeys Fed with a Silage-Composed Diet Modified with Different Diet Cation–Anion Differences (Dcads)
    • Authors: Wójcik, M., Stachal, K., Burzec, M., Gruszczyński, K., Korga-Plewko, A.
    • Publication Year: 2022
    • Citations: 0
  4. Apigenin and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity
    • Authors: Korga-Plewko, A., Michalczyk, M., Adamczuk, G., Wójcik, M., Dudka, J.
    • Publication Year: 2020
    • Citations: 22
  5. Relationship Between Mammary Blood Flow, Infrared Thermography and Ovine Placental Lactogen During the Periparturient Period in Ewes
    • Authors: Bobowiec, R., Wójcik, M., Milczak, A., Gregula-Kania, M., Tatarczak, J.
    • Publication Year: 2019
    • Citations: 1
  6. Influence of Proinflammatory Macrophages (M-1) on Proliferative Activity and PPAR Expression in Neoplastic Rat Hepatocytes In Vitro
    • Authors: Wójcik, M., Kosior-Korzecka, U., Plewik, M., Bobowiec, R.
    • Publication Year: 2019
    • Citations: 0
  7. Changes in Growth Hormone Secretion and Leptin Receptor mRNA Expression Under the Influence of Leptin and Adrenocorticotropin in Pituitary Cells of Early Weaned Ewe Lambs
    • Authors: Kosior-Korzecka, U., Wójcik, M., Longo, V., Patkowski, K., Gregula-Kania, M.
    • Publication Year: 2019
    • Citations: 5
  8. Expression of Receptor Interacting Protein 1 and Receptor Interacting Protein 3 Oval Cells in a Rat Model of Hepatocarcinogenesis
    • Authors: Wójcik, M., Bobowiec, R., Lisiecka, U., Śmiech, A.
    • Publication Year: 2018
    • Citations: 3
  9. Growth Rate and Acid-Base Balance in Turkeys Fed a Silage-Containing Diet Modified by Different Dietary Cation-Anion Difference
    • Authors: Gruszczyński, K., Strobel, W., Wójcik, M., Wessely-Szponder, J., Bobowiec, R.
    • Publication Year: 2017
    • Citations: 1
  10. In Vitro Proinflammatory Polarization of Macrophages Isolated from Hepatocarcinogenic Stage in Humans and Rats
    • Authors: Wójcik, M., Wessely-Szponder, J., Cichoz-Lach, H., Celiński, K., Bobowiec, R.
    • Publication Year: 2016
    • Citations: 4

Conclusion 🔚

Dr. Marta Wójcik’s extensive education, diverse experience, and dedicated research have established her as a leading figure in veterinary pathology, particularly in the study of liver diseases and cancer processes. Her ongoing contributions continue to advance the understanding of hepatocarcinogenesis, benefiting both the scientific community and veterinary medicine.